Showing results (401-410 of 418) with videos related to

Sort By:
Pageof 42
American Journal of Surgery|August 1, 1981
A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent diseaseC L Day, A J Sober, A W Kopf, et al.
British Journal of Cancer|February 25, 2012
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohortJ Cuzick, D M Berney, G Fisher, et al.
British Journal of Cancer|August 27, 2009
Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangementC S Foster, A R Dodson, L Ambroisine, et al.
Oncogene|October 9, 2007
Complex patterns of ETS gene alteration arise during cancer development in the human prostateJ Clark, G Attard, S Jhavar, et al.
Oncogene|October 18, 2006
Diversity of TMPRSS2-ERG fusion transcripts in the human prostateJ Clark, S Merson, S Jhavar, et al.
American Journal of Ophthalmology|October 12, 2000
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panelD A Jabs, J T Rosenbaum, C S Foster, et al.
British Journal of Cancer|February 1, 2014
Focal amplification of the androgen receptor gene in hormone-naive human prostate cancerS Merson, Z H Yang, D Brewer, et al.
Annals of Surgery|April 1, 1981
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent diseaseC L Day, A J Sober, A W Kopf, et al.
Gut|July 11, 1998
In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allograftsS D Taylor-Robinson, J Sargentoni, J D Bell, et al.
Oncogene|July 20, 2007
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancerG Attard, J Clark, L Ambroisine, et al.
Pageof 42